Positron Emission Tomography Facility
Core Director: Daniel Y. Lee, MD, PhD
To learn more or schedule resources for this core, please login to iLab or contact our core director.
Daniel Y. Lee, M.D., Ph.D.
The Positron Emission Tomography (PET) Facility at Houston Methodist offers a wide variety of highly customizable advanced imaging services including the production of cGMP grade radiopharmaceuticals and research-dedicated PET scanning of patients and large preclinical models. The production of radiopharmaceuticals is performed by the Cyclotron and Radiopharmaceutical Core in compliance with FDA regulatory requirements. There are currently several ongoing research studies involving novel tracers for imaging of brain tumors and neurodegenerative diseases. Additional novel radiopharmaceuticals which are in the pipeline will be helpful for imaging molecular processes involving inflammation and for specific protein detection such as tau. For more on the tracer production component of our core, visit the Cyclotron and Radiopharmaceutical Core.